Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Immunogenicity
92%
Pharmacokinetics
70%
Healthy Volunteers
63%
Healthy Adults
54%
Israel
51%
Persian Gulf War
43%
Chemical Warfare
43%
Placebo
38%
Well Tolerated
36%
Multimeric-001
35%
Universal Vaccine
35%
Melatonin
35%
Pyridostigmine
35%
Chemical Protective
35%
Protective Gear
35%
Cannabidiol
31%
Israeli
29%
Air Supply
26%
Respiratory Protective Equipment
26%
Acetylcholinesterase
25%
Decontamination
23%
Human Subjects
23%
Emergency Medical Technicians
23%
Benzodiazepines
22%
Blood Levels
21%
Recombinant Hepatitis B Vaccine
21%
Adult Volunteers
20%
Dose Escalation
20%
Adverse Events
20%
Organophosphate Poisoning
20%
Routine Monitoring
19%
Phase 1 Study
19%
First-in-human
19%
Randomized Placebo-controlled Trial
19%
Functional Adaptation
17%
Human Evaluation
17%
Pre-S
17%
S-antigen
17%
Hormone Suppression
17%
Respiration Parameters
17%
Line Insertion
17%
Thallium Poisoning
17%
In Vivo Performance
17%
Infusion System
17%
Non-benzodiazepine
17%
Consanguinity
17%
Dispersion Technology
17%
Benzodiazepine Binding Site
17%
Pharmacological Assessment
17%
Intravenous Line
17%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Normal Human
99%
Immunogenicity
61%
Placebo
39%
Toxic Injury
38%
Nerve Gas
37%
Hepatitis B Antibody
35%
Pyridostigmine
35%
Cannabidiol
31%
Adverse Event
29%
Acetylcholinesterase
28%
Antigen
28%
Recombinant Hepatitis B Vaccine
26%
Hepatitis B
26%
Placebo-Controlled Study
24%
Chemical Warfare Agent
23%
Homo sapiens
23%
Bioavailability
21%
Clinical Study
20%
Carbohydrates
19%
Melatonin
17%
Benzodiazepine
17%
Growth Hormone
17%
Ketoconazole
17%
Live Attenuated Influenza Vaccine
17%
Hepatitis B Vaccine
17%
Glycoconjugate
17%
Gas Poisoning
17%
Rivastigmine
17%
Phase IV
17%
Macitentan
17%
Endothelin Receptor Antagonist
17%
Recombinant Vaccine
17%
Shigella flexneri
17%
Conjugate Vaccine
17%
Octreotide
17%
Beta Adrenergic Receptor Blocking Agent
17%
Hepatitis B Virus
17%
Chinese Hamster
17%
Theophylline
17%
Fluorouracil
17%
Sorafenib
17%
Folinic Acid
17%
Vesiculovirus
17%
Vaccine Development
17%
COVID-19 Vaccine
17%
SARS Coronavirus
17%
Solid Malignant Neoplasm
17%
Viral Vector
17%
Cannabinoid
17%